Thromb Haemost 1971; 26(02): 224-234
DOI: 10.1055/s-0038-1653671
Originalarbeiten – Original Articles – Travaux Originaux
Schattauer GmbH

Purification and Properties of the Thrombin-Like Principle of Agkistrodon acutus Venom and Its Comparison with Bovine Thrombin

Chaoho Ouyang
1   Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, China
,
Jau-Shyong Hong
1   Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, China
,
Che-Ming Teng
1   Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan, China
› Author Affiliations
Further Information

Publication History

Publication Date:
28 June 2018 (online)

Summary

By means of DEAE-Sephadex column chromatography, Agkistrodon acutus venom was separated into 12 fractions. The thrombin-like activity was concentrated in Fr.10. This fraction was rechromatographed on Sephadex G-200. A single band was found on microzone electrophoresis at pH 7.4. A single boundary with S20, w of 3.82 S, which was almost symmetrical, was observed by ultracentrifugation. The estimated molecular weight is 33,500. The chemical analysis shows that the thrombin-like principle of the venom is a glycoprotein. The specific activity is 13 times higher than that of the crude venom. The optimal pH value of the thrombin-like principle (pH 7.5) of the venom is almost identical with that of the bovine thrombin (pH 7.2). The thrombinlike principle of the venom is not affected by heparin, while the clotting activity of the bovine thrombin is inhibited by heparin. The thrombin-like principle of the venom is much more heat stable than the bovine thrombin.

No clot retraction was found with the thrombin-like principle of the venom, while the marked clot retraction occurred after plasma was coagulated with thrombin.

Thrombin can activate factor XIII (Fibrin stabilizing factor), while the thrombinlike principle can not.

 
  • References

  • 1 Andrews P. Estimation of the molecular weights of proteins by Sephadex gel filtration. Biochem. J 91: 222 1964;
  • 2 Arthus M. Action coagulants et anticoagulantes des veins. Arch. int. Physiol 14: 203 1919;
  • 3 Blombäck B, Blombäck M. Thrombos. Diathes. haemorrh. (Stuttg) 01: 76 1957;
  • 4 Blombäck B. Arkiv Kemi. 12: 321 1958;
  • 5 Cheng H. G, Ouyang C. Isolation of coagulant and anticoagulant principles from the venom of Agkistrodon acutus. Toxicon 04: 235 1967;
  • 6 Devi A, Mitra S. N, Sarkar N. K. Antikoagulation action of cobra venom. In: Venoms. Vol. 12 Washington: A.A.A. S: 217 1956.
  • 7 Dubois M, Gilles K. A, Hamilton J. K, Rebers P. A, Smith F. Colorimetric method for determination of sugars and related substances. Analyt. Chem 28: 350 1956;
  • 8 Eagle H. The coagulation of blood by snake venoms and its physiologic significance. J. exp. Med 65: 613 1937;
  • 9 Esnouf M. P, Tunnah G. W. The isolation and properties of the thrombin-like activity from Ancistrodon rhodostoma venom. Brit. J. Haemat 13: 581 1967;
  • 10 Fleckenstein A, Fettig O. Über den Einfluß von Oxalat, Citrat, Fluorid und Phlorezin auf die Zerstörung der Thrombokinase durch Bienengift und Schlangengifte. Arch. exp. Path. Pharmak 216: 415 1952;
  • 11 Habermann E. Über das thrombinähnlich wirkende Prinzip von Jararagift. Arch. exp. Path. Pharmak 234: 291 1958;
  • 12 Harmison G. R, Landaburu R. H, Seegers W. H. Some physicochemical properties of bovine thrombin. J. biol. Chem 236: 1693 1961;
  • 13 Houssay B. A, Sordelli A. Action des venine de serpents sur la coagulation sanguine. J. Physiol. Path. gén 18: 781 1919;
  • 14 Kondo H, Kondo S, Ikezawa H, Murata R, Ohsaka A. Studies on the quantitative method for determination of hemorrhagic activity of habu snake venom. Jap. J. med. Sci. Biol 13: 43 1960;
  • 15 Lee C. Y, Johnson S. A, Seegers W. H. Clotting of blood with Russell’s viper venom. J. Mich. St. med. Soc 54: 801 1955;
  • 16 Litchfield J. R, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol, exp. Ther 96: 99 1949;
  • 17 Link I, Dam H. Inactivations of thromboplastin by cobra venom. Biochim. biophys. Acta (Amst) 05: 268 1950;
  • 18 Maeno H, Mitsuhashi S. Studies on habu snake venom-2C. Studies on H-proteinase of habu venom. Jap. J. Microbiol 04: 173 1960;
  • 19 Martin G. J. Observation upon fibrin-ferments in the venom of snakes and the time- relations of their action. J. Physiol 32: 207 1905;
  • 20 Mellanby J. The coagulation of blood. Part II. The actions of snake venom, peptone and leach extract. J. Physiol 38: 441 1909;
  • 21 Miller K. D, Brown R. K, Cusillus G, Seegers W. H. Thrombos. Diathes. haemorrh. (Stuttg) 03: 362 1959;
  • 22 Morawitz P. Die Chemie der Blutgerinnung. Ergebn. Physiol 04: 307 1905;
  • 23 Oh J. Experimentelle Untersuchungen über den Einfluß der wichtigeren formosanischen Schlangengifte auf die Koagulation des Kaninchenblutes in vitro. Jap. J. med. Sci., Pharmac 12: 31 1938;
  • 24 Ouyang G. The effects of Formosan snake venoms on blood coagulation in vitro. J. Formosan med. Ass 56: 435 1957;
  • 25 Seegers W. H. Purification of prothrombin and thrombin: Chemical properties of purified preparations. J. biol. Chem 136: 103 1940;
  • 26 Seegers W. H, Smith H. P. Factors which influence the activity of purified thrombin. Amer. J. Physiol 137: 348 1942;
  • 27 Shiau S. Y, Ouyang G. Isolation of coagulant and anticoagulant principles from the venom of Trimeresurus gramineus. Toxicon 02: 213 1965;